Jean-Philippe Lacour Selected Research

Interleukin-2 (IL2)

1/2021	Low-Dose IL-2 for Treating Moderate to Severe Alopecia Areata: A 52-Week Multicenter Prospective Placebo-Controlled Study Assessing its Impact on T Regulatory Cell and NK Cell Populations.
7/2014	Effects of low-dose recombinant interleukin 2 to promote T-regulatory cells in alopecia areata.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jean-Philippe Lacour Research Topics

Disease

17	Melanoma (Melanoma, Malignant) 10/2019 - 01/2011
15	Psoriasis (Pustulosis Palmaris et Plantaris) 06/2022 - 04/2015
7	Atopic Dermatitis (Atopic Eczema) 10/2022 - 04/2015
6	Neoplasms (Cancer) 11/2018 - 12/2011
4	Nevus (Nevi) 12/2020 - 01/2011
4	Vitiligo 01/2020 - 09/2004
3	Eczema 01/2022 - 12/2016
3	Alopecia Areata 01/2021 - 11/2004
3	Pruritus (Itching) 01/2020 - 09/2015
3	Body Weight (Weight, Body) 01/2020 - 10/2015
3	Epidermolysis Bullosa Dystrophica (Dystrophic Epidermolysis Bullosa) 03/2016 - 10/2004
3	Hyperpigmentation 12/2015 - 06/2013
3	Melanosis (Freckles) 07/2015 - 09/2011
2	Conjunctivitis 07/2019 - 12/2016
2	Hemangioma (Angioma) 01/2018 - 05/2011
2	Neoplasm Metastasis (Metastasis) 01/2012 - 12/2011
2	Bullous Pemphigoid (Pemphigoid) 11/2011 - 09/2008
1	Pain (Aches) 01/2022
1	Nasopharyngitis 01/2022
1	Human Influenza (Influenza) 01/2022
1	Herpes Simplex 01/2022
1	Headache (Headaches) 01/2022
1	Inflammation (Inflammations) 03/2021
1	Hamartoma 12/2020
1	Epidermal Nevus 12/2020
1	Hutchinson's Melanotic Freckle (Lentigo Maligna) 01/2020
1	Diarrhea 01/2020
1	Prurigo 01/2020
1	Abdominal Pain (Pain, Abdominal) 01/2020
1	Pneumonia (Pneumonitis) 10/2019
1	Eosinophilia 07/2019
1	Brain Neoplasms (Brain Tumor) 01/2019
1	Erythema 01/2019
1	Benign Familial Pemphigus (Hailey Hailey Disease) 12/2018
1	Glycogen Storage Disease Type VI (Glycogenosis Type VI) 12/2018
1	Epidermolysis Bullosa Simplex (Epidermolysis Bullosa Herpetiformis Dowling Meara) 05/2018
1	Elastosis perforans serpiginosa 10/2017
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 04/2017
1	Hidradenitis Suppurativa 01/2017
1	Basal Cell Carcinoma (Rodent Ulcer) 01/2017

Drug/Important Bio-Agent (IBA)

6	betamethasone-17,21-dipropionate (betamethasone dipropionate)FDA LinkGeneric 06/2022 - 04/2015
6	calcipotriene (calcipotriol)FDA LinkGeneric 06/2022 - 04/2015
6	Monoclonal AntibodiesIBA 01/2020 - 01/2011
4	Biological ProductsIBA 01/2022 - 06/2019
4	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 03/2015
4	Ustekinumab (CNTO 1275)FDA Link 08/2020 - 10/2015
4	Tacrolimus (Prograf)FDA LinkGeneric 04/2015 - 10/2002
3	AerosolsIBA 06/2022 - 04/2015
3	apremilastIBA 01/2020 - 12/2016
3	dupilumabIBA 01/2020 - 12/2016
3	Proteins (Proteins, Gene)FDA Link 05/2018 - 01/2012
3	VemurafenibIBA 01/2017 - 08/2012
2	Interleukin-2 (IL2)IBA 01/2021 - 07/2014
2	CytokinesIBA 01/2019 - 12/2016
2	brodalumabIBA 10/2018 - 10/2015
2	Propranolol (Inderal)FDA LinkGeneric 01/2018 - 05/2011
2	Transcription Factors (Transcription Factor)IBA 01/2017 - 01/2012
2	Mitogen-Activated Protein KinasesIBA 05/2015 - 08/2012
2	ErbiumIBA 03/2015 - 11/2013
2	DNA (Deoxyribonucleic Acid)IBA 12/2011 - 12/2008
2	AutoantibodiesIBA 11/2011 - 09/2008
2	Collagen Type VIIIBA 10/2010 - 10/2004
1	Interleukin-33IBA 10/2022
1	baricitinibIBA 01/2022
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2022
1	Janus KinasesIBA 01/2022
1	Immunoglobulin E (IgE)IBA 03/2021
1	ixekizumabIBA 08/2020
1	nemolizumabIBA 01/2020
1	3-ingenyl angelateIBA 01/2020
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 10/2019
1	NivolumabIBA 10/2019
1	Etanercept (Enbrel)FDA Link 06/2019
1	Adalimumab (Humira)FDA Link 06/2019
1	Prostaglandins AIBA 06/2019
1	Caspase 1 (ICE Protease)IBA 01/2019
1	N-acetyl-tyrosyl-valyl-alanyl-aspartyl chloromethyl ketoneIBA 01/2019
1	CaspasesIBA 01/2019
1	alanylaspartic acidIBA 01/2019
1	Circulating Tumor DNAIBA 11/2018
1	Cell-Free Nucleic AcidsIBA 11/2018
1	Interleukin-17 (Interleukin 17)IBA 10/2018
1	secukinumabIBA 10/2018
1	Interleukin-17 ReceptorsIBA 10/2018
1	Keratin-14 (Keratin 14)IBA 05/2018
1	Biomarkers (Surrogate Marker)IBA 04/2017
1	Cetuximab (Erbitux)FDA Link 04/2017
1	C-Reactive ProteinIBA 01/2017

Therapy/Procedure

12	Therapeutics 01/2022 - 10/2002
8	Lasers (Laser) 12/2020 - 01/2013
2	Biological Therapy 10/2020 - 06/2019
2	Radiotherapy 01/2019 - 10/2017
2	Dye Lasers 09/2011 - 05/2009
2	Solid-State Lasers 07/2011 - 02/2011
2	Excimer Lasers 11/2004 - 09/2004
1	Contraindications 01/2022
1	Aftercare (After-Treatment) 11/2020
1	Immunotherapy 10/2019
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2019
1	Gas Lasers 10/2017